BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 37275867)

  • 1. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
    Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
    World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Lv L; Wang C
    Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
    Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Xu D; Chen VL; Steiner CA; Berinstein JA; Eswaran S; Waljee AK; Higgins PDR; Owyang C
    Am J Gastroenterol; 2019 Jul; 114(7):1043-1050. PubMed ID: 30908299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis.
    Elhusein AM; Fadlalmola HA
    Gastroenterol Nurs; 2022 Jan-Feb 01; 45(1):11-20. PubMed ID: 35108241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
    Myneedu K; Deoker A; Schmulson MJ; Bashashati M
    United European Gastroenterol J; 2019 Oct; 7(8):1033-1041. PubMed ID: 31662860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.
    Samuthpongtorn C; Kantagowit P; Pittayanon R; Patcharatrakul T; Gonlachanvit S
    Front Med (Lausanne); 2022; 9():1039284. PubMed ID: 36405622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamshidi P; Farsi Y; Nariman Z; Hatamnejad MR; Mohammadzadeh B; Akbarialiabad H; Nasiri MJ; Sechi LA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
    Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
    J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
    PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Zhao HJ; Zhang XJ; Zhang NN; Yan B; Xu KK; Peng LH; Pan F
    Front Nutr; 2022; 9():890357. PubMed ID: 35719141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.